| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |